Global In Vitro Toxicology Testing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global In Vitro Toxicology Testing Market Research Report 2024
In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives.
According to MRAResearch’s new survey, global In Vitro Toxicology Testing market is projected to reach US$ 10240 million in 2033, increasing from US$ 6930.4 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In Vitro Toxicology Testing market research.
Europe is projected to account for the largest share of the global market. The demand for in vitro toxicology testing in Europe is driven by the increasing number of investments in research and innovation by the European Commission to develop alternative methods to animal testing. The European Union has been a leader in supporting research to advance the development and validation of in vitro toxicology testing protocols for regulatory purposes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In Vitro Toxicology Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
SGS
Covance
Bio-Rad Laboratories
Qiagen
GE Healthcare
Eurofins Scientific
Merck
Thermo Fisher
Charles River Laboratories International
Catalent
Cyprotex
Promega
Gentronix Limited
Ascendance Biotechnology
MB Research Laboratories
Segment by Type
Cell Culture Technology
High-throughput Technology
Cellular Imaging Technology
Toxicogenomics
Pharmaceuticals & Biopharmaceuticals Industry
Cosmetics and Household Products Industry
Food Industry
Chemicals Industry
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In Vitro Toxicology Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source![](http://localhost/mraccuracy/images/About Report.webp)
According to MRAResearch’s new survey, global In Vitro Toxicology Testing market is projected to reach US$ 10240 million in 2033, increasing from US$ 6930.4 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In Vitro Toxicology Testing market research.
Europe is projected to account for the largest share of the global market. The demand for in vitro toxicology testing in Europe is driven by the increasing number of investments in research and innovation by the European Commission to develop alternative methods to animal testing. The European Union has been a leader in supporting research to advance the development and validation of in vitro toxicology testing protocols for regulatory purposes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In Vitro Toxicology Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
SGS
Covance
Bio-Rad Laboratories
Qiagen
GE Healthcare
Eurofins Scientific
Merck
Thermo Fisher
Charles River Laboratories International
Catalent
Cyprotex
Promega
Gentronix Limited
Ascendance Biotechnology
MB Research Laboratories
Segment by Type
Cell Culture Technology
High-throughput Technology
Cellular Imaging Technology
Toxicogenomics
Segment by Application
Pharmaceuticals & Biopharmaceuticals Industry
Cosmetics and Household Products Industry
Food Industry
Chemicals Industry
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In Vitro Toxicology Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
![](http://localhost/mraccuracy/images/About Report.webp)